Brief: Invo Bioscience Inc Expects Total Revenue In Q4 Of 2022 To Reflect A Sequential Increase Of Approximately 15% To 19%
30/03/2023 22:45
March 30 (Reuters) - INVO Bioscience Inc INVO.O :
* INVO BIOSCIENCE INC - EXPECTS TOTAL REVENUE IN Q4 OF 2022
TO
REFLECT A SEQUENTIAL INCREASE OF APPROXIMATELY 15% TO 19%
Source text for Eikon: ID:nPn3PJF8ya
Further company coverage: INVO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on INVO Fertility
See all newsINVO Fertility Q2 revenue rises, partly on acquisitions
Invo Fertility Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Invo Fertility Inc Expected To Post A Loss Of 70 Cents A Share: Earnings Preview
Brief: INVO Fertility - Entered Into Any Market Purchase Agreement With Alumni Capital Lp
Invo Fertility Inc Reports Results For The Quarter Ended March 31: Earnings Summary